The role of factor VII in the coagulation process appears to be two-fold. First, Biggs, Douglas and MacFarlane (1953) showed it to be essential for the evolution of plasma thromboplastin, while Koller et al. (1951) and Owren (1951b) have demonstrated its role as a prothrombin conversion accelerator, and as a co-factor for tissue thromboplastin, being essential for the normal reaction of brain emulsion and prothrombin.
Factor VII deficiency may be either congenital or acquired. In the acquired category may be grouped deficiency resulting from therapeutic administration of the coumarin group of drugs, deficiency in hepatic disease, and in the newborn.
Cases of congenital deficiency of factor VII are rare; before 1950 they were reported in common with cases of factor V deficiency as hypoprothrombinaemias on account of the misconception then prevailing that the single-stage prothrombin time was a measure of plasma prothrombin.
A total of 14 cases designated as a deficiency of a serum factor, and probably corresponding to factor VII deficiency, have been found in the literature. Biggs and MacFarlane (1953) give some details of three probable cases of factor VII deficiency described before the factor itself was adequately characterized. These were the cases of Giordano (1943) , Crockett, Shotton, Craddock and Leavell (1949) and Landwehr, Lang and Alexander (1950) . Frick Beaumont and Bernard (1953) described a case in a newborn baby. Lewis, Fresh and Ferguson (1953) describe two cases, one in a girl who died of haemorrhage at the age of 14 years, and one in a man of 32 years, and Jenkins (1954) a further case. Bell and Alton (1955) describe a case in a 29-year-old man in whom the condition was associated with Christmas disease, while de Vries, Kettenborg and van der Pol (1955) 
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The test was performed as described by Biggs and MacFarlane (1953). 0-3 ml. amounts of each reagent were incubated together as the reaction mixture and 0-1 ml. transferred to 0-1 ml. normal citrated plasma. The clotting time of this substrate is given in seconds. The possibility of a thromboplastin inhibitor being present was considered. To exclude the presence of such a factor, the recalcification time of various mixtures of the patient's and normal plasma was determined before and after incubation for two hours at 370 C. The results are shown in Table 2 . The prothrombin content of the patient's plasma was determined by the two-stage method (Biggs and Douglas, 1953) , with comparison of the areas. The curves of the patient and a normal are shown in Fig. 2 , and the area of the normal is 17 sq. cm.; of the abnormal 21 sq. cm. (Biggs and MacFarlane, 1953) to the patient's plasma used in the thromboplastin time test completely corrected the defect.
The prothrombin consumption test was carried out as described by Merskey (1950) . The plasma time was 50 seconds and the serum time 8 minutes, giving a prothrombin consumption index of 11%. This test was repeated after the addition of 10% of normal serum which had been incubated at 37°C. for two hours and aged at + 40 C. for 48 hours to ensure prothrombin It is clear from the foregoing data, summarized in Table 3 , that the patient's deficiency was one of factor VII. It was found that the patient's own serum (after incubation for three hours at 37°C.) was to some extent efficacious in correcting the defective thromboplastin time. This anomaly was also noted by Crockett et al. (1949) , Jenkins (1954) and de Vries et al. (1955, case 2) in their cases.
The addition of a very small amount of thrombin (Parke-Davis 'topical thrombin') to the single-stage thromboplastin time resulted in complete correction. After absorption of the thrombin solution with Al(OH3) there was no correction, suggesting that commercial thrombin may be contaminated with factor VII, a possibility supported by the work of Frick and Hagen (1953) .
Spontaneous activation of the patient's plasma on standing was noted; and the thromboplastin time was longest when performed without delay. After two to three hours the time fell to about 65 seconds, about which level it then remained stable for some time.
Tests were carried out on the mother, father, paternal grandmother and grandfather, but no abnormality was found in any of these.
Discussion
Congenital factor VII deficiency is a rare condition; 10 of the 15 published cases have occurred in males. It seems very probable from the published cases that it is familial. In the present case the presumption is strong, although no tests were performed on the elder brother, that he suffered from a similar deficiency. Whether the fact that the parents are first cousins is of import is not known; neither shows any evidence of a factor VII deficiency, and there is no clear history of haemorrhagic diathesis in the family. The similarity of the case presented here with that described by Landwehr et al. (1950) 
